Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AYO is the commercial brand of Novalogy, a private health technology company focused on circadian health. Its main product is a wearable light-therapy device, marketed as AYO or AYO+, paired with a mobile app that provides personalized guidance intended to improve sleep-wake alignment, energy, jet-lag adaptation, and general wellbeing. The company operates in the health and wellness / digital health category rather than as a therapeutics developer, and its product is sold directly to consumers as a non-medical wellness device. The platform is built around chronobiology and light-based behavioral intervention rather than drugs or biologics. For a biotech or healthcare analyst, AYO is best categorized as a commercial-stage circadian-health wearable company with a device-plus-software offering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AYO.